293 related articles for article (PubMed ID: 15585566)
21. Differential effects of estradiol, raloxifene and tamoxifen on estrogen receptor expression in cultured human skin fibroblasts.
Haczynski J; Tarkowski R; Jarzabek K; Wolczynski S; Magoffin DA; Czarnocki KJ; Ziegert M; Jakowicki J; Jakimiuk AJ
Int J Mol Med; 2004 Jun; 13(6):903-8. PubMed ID: 15138633
[TBL] [Abstract][Full Text] [Related]
22. Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease.
O'Neill K; Chen S; Brinton RD
Exp Neurol; 2004 Jan; 185(1):63-80. PubMed ID: 14697319
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene.
Miki Y; Suzuki T; Nagasaki S; Hata S; Akahira J; Sasano H
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):281-9. PubMed ID: 19429434
[TBL] [Abstract][Full Text] [Related]
24. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
[TBL] [Abstract][Full Text] [Related]
25. The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease.
Baraka AM; Korish AA; Soliman GA; Kamal H
Life Sci; 2011 May; 88(19-20):879-85. PubMed ID: 21420980
[TBL] [Abstract][Full Text] [Related]
26. The cardiovascular effects of selective estrogen receptor modulators.
Christodoulakos GE; Lambrinoudaki IV; Botsis DC
Ann N Y Acad Sci; 2006 Dec; 1092():374-84. PubMed ID: 17308162
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effects of the Alzheimer's disease-related gene seladin-1.
Peri A; Serio M
J Mol Endocrinol; 2008 Nov; 41(5):251-61. PubMed ID: 18768664
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
Michael H; Härkönen PL; Kangas L; Väänänen HK; Hentunen TA
Br J Pharmacol; 2007 Jun; 151(3):384-95. PubMed ID: 17420779
[TBL] [Abstract][Full Text] [Related]
29. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
30. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
Gielen SC; Burger CW; Kühne LC; Hanifi-Moghaddam P; Blok LJ
J Soc Gynecol Investig; 2005 Oct; 12(7):e55-67. PubMed ID: 16202921
[TBL] [Abstract][Full Text] [Related]
31. Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas.
Luciani P; Ferruzzi P; Arnaldi G; Crescioli C; Benvenuti S; Nesi G; Valeri A; Greeve I; Serio M; Mannelli M; Peri A
J Clin Endocrinol Metab; 2004 Mar; 89(3):1332-9. PubMed ID: 15001630
[TBL] [Abstract][Full Text] [Related]
32. Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the neuroprotective factor DHCR24 (Seladin-1).
Giannini S; Benvenuti S; Luciani P; Manuelli C; Cellai I; Deledda C; Pezzatini A; Vannelli GB; Maneschi E; Rotella CM; Serio M; Peri A
J Endocrinol; 2008 Sep; 198(3):523-32. PubMed ID: 18612048
[TBL] [Abstract][Full Text] [Related]
33. Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.
Ishihara Y; Itoh K; Ishida A; Yamazaki T
J Steroid Biochem Mol Biol; 2015 Jan; 145():85-93. PubMed ID: 25305410
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells.
Salvatori L; Caporuscio F; Coroniti G; Starace G; Frati L; Russo MA; Petrangeli E
J Cell Physiol; 2009 Jul; 220(1):35-44. PubMed ID: 19347870
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms mediating the neuroprotective role of the selective estrogen receptor modulator, bazedoxifene, in acute ischemic stroke: A comparative study with 17β-estradiol.
Jover-Mengual T; Castelló-Ruiz M; Burguete MC; Jorques M; López-Morales MA; Aliena-Valero A; Jurado-Rodríguez A; Pérez S; Centeno JM; Miranda FJ; Alborch E; Torregrosa G; Salom JB
J Steroid Biochem Mol Biol; 2017 Jul; 171():296-304. PubMed ID: 28479229
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells.
Suuronen T; Nuutinen T; Huuskonen J; Ojala J; Thornell A; Salminen A
Inflamm Res; 2005 May; 54(5):194-203. PubMed ID: 15953991
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effects of estrogens: the role of cholesterol.
Peri A
J Endocrinol Invest; 2016 Jan; 39(1):11-8. PubMed ID: 26084445
[TBL] [Abstract][Full Text] [Related]
38. Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model.
Bläuer M; Heinonen PK; Rovio P; Ylikomi T
Eur J Pharmacol; 2008 Sep; 592(1-3):13-8. PubMed ID: 18638473
[TBL] [Abstract][Full Text] [Related]
39. Raloxifene elicits combined rapid vasorelaxation and long-term anti-inflammatory actions in rat aorta.
Pinna C; Bolego C; Sanvito P; Pelosi V; Baetta R; Corsini A; Gaion RM; Cignarella A
J Pharmacol Exp Ther; 2006 Dec; 319(3):1444-51. PubMed ID: 16943257
[TBL] [Abstract][Full Text] [Related]
40. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile.
Zhao L; O'Neill K; Brinton RD
J Pharmacol Exp Ther; 2006 Dec; 319(3):1124-32. PubMed ID: 16951259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
